Merck, referred to as MSD outside the U.S. and Canada, revealed top-line findings from the crucial double-blind phase 3 trial of the experimental, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir [DOR/ISL (100 mg/0.25 mg)]
Pfizer has joined hands with the Pragyaan Sustainable Health Outcomes Foundation (PRASHO) to roll out a new series of migraine awareness and workplace productivity workshops across major corporate offices in Hyderabad. The initiative addresses...
Under the brand name Lynkuet, elinzanetant has been authorized for marketing in the European Union (EU) by the European Commission. The medication is authorized for the management of moderate to severe vasomotor symptoms (VMS; also called hot flashes
Roche revealed favorable phase III outcomes from the lidERA Breast Cancer trial assessing the experimental giredestrant as an adjunctive endocrine therapy for individuals with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2
Glenmark Pharmaceuticals has obtained marketing approval from the European Commission (EC) for Winlevi (clascoterone 10 mg/g cream), an innovative topical solution for acne, in 15 European nations
Birla Fertility & IVF, one of India’s fastest-growing fertility networks and part of the multibillion-dollar CKA Birla Group, today reaffirmed its commitment to transparency, ethical practices, and clinical excellence with the launch of its new...
.png)
Pfizer has introduced Rimegepant, a calcitonin gene-related peptide treatment for migraine, marking a notable expansion of its neuroscience portfolio in India. The company said the 75 mg orally disintegrating tablet is designed for adults who need...
.png)
Alembic Pharmaceuticals today received its final USFDA clearance of its ANDA of Diltiazem Hydrochloride Tablets 30mg, 60mg, 90mg, and 120mg. This is a strategic victory that strengthens the position of the U.S. generics market of Alembic...
.png)
Pfizer acquisition news took center stage today as the company confirmed it has closed its purchase of Metsera, a clinical-stage biotech pushing new treatments for obesity and cardiometabolic disease. The move marks a major step for Pfizer as it...
Sun Pharmaceutical Industries Limited (Sun Pharma), India’s leading pharmaceutical company by revenue and prescriptions, has rolled out the #SeeBeyondSugar campaign — a national initiative aimed at boosting awareness and education around diabetic
.jpg)
, CDSCO.jpg)